Taysha Gene Therapies, Inc. (TSHA)
NASDAQ·Healthcare·Biotechnology
$4.25
+0.24%
Mkt Cap $1.29B
Analyst Ratings
Buy
6
Hold
0
Sell
0
Price Target (18 analysts)
$14.00
Range $13.00 – $15.00
Implied Upside
+229.4%
Consensus $14.00 vs current $4.25
NASDAQ·Healthcare·Biotechnology
$4.25
+0.24%
Mkt Cap $1.29B
Buy
6
Hold
0
Sell
0
Price Target (18 analysts)
$14.00
Range $13.00 – $15.00
+229.4%
Consensus $14.00 vs current $4.25